Search

Author/Creator Saeki, Hidehisa

1. 309 Tralokinumab demonstrated a consistent safety profile with up to 42 months of treatment in moderate-to-severe atopic dermatitis: including adverse events of special interest. (25th January 2023)

Authors:
Reich, Kristian; Simpson, Eric; Langley, Richard; Warren, Richard B; Costanzo, Antonio; Saeki, Hidehisa; Almgren, Peter; Gjerum, Le; Carlsson, Anna; Gooderham, Melinda; Pinter, Andreas; De Bruin Weller, Marjolein; Blauvelt, Andrew 
Journal:
British journal of dermatology
Issue:
Volume 188(2023)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Adalimumab markedly improves enthesitis in patients with psoriatic arthritis: Evaluation with a magnetic resonance imaging scoring system. Issue 12 (24th June 2015)

Authors:
Yanaba, Koichi; Sadaoka, Akari; Yonenaga, Takenori; Saeki, Hidehisa; Umezawa, Yoshinori; Tojo, Shinjiro; Ito, Toshihiro; Kikuchi, Sota; Fukuda, Kunihiko; Nakagawa, Hidemi
Journal:
Journal of dermatology
Issue:
Volume 42:Issue 12(2015)
Page Start:
1153
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Assessment of medication adherence and treatment satisfaction in Japanese patients with psoriasis of various severities. Issue 6 (21st January 2018)

Authors:
Ichiyama, Susumu; Ito, Michiko; Funasaka, Yoko; Abe, Masatoshi; Nishida, Emi; Muramatsu, Shinnosuke; Nishihara, Haruna; Kato, Hiroshi; Morita, Akimichi; Imafuku, Shinichi; Saeki, Hidehisa
Journal:
Journal of dermatology
Issue:
Volume 45:Issue 6(2018)
Page Start:
727
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗